Pain Management News and Research

RSS

Long-term use of opioid prescriptions by veterans

Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

23 Nov 2004

More research and innovation on child pain and stress reduction is needed

Relief of pain and stress for children receiving emergency medical treatment is a vital, and readily available, component of care.

1 Nov 2004

Global effort to relieve chronic pain

The World Health Organization (WHO) co-sponsors the first Global Day Against Pain, which seeks to draw global attention to the urgent need for better pain relief for sufferers from diseases such as cancer and AIDS.

11 Oct 2004

Genes in poppy could hold the key to producing improved pain management pharmaceuticals

"The genes we found behaved differently in Norman compared to standard morphine producing poppies and were consistently associated with the blockage in morphine synthesis and with the accumulation of thebaine and oripavine," Dr Larkin says.

23 Sep 2004

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

A beautiful, but often deadly, snail from the sea has been revealed as a largely untapped source of natural healing powers for a range of illnesses from chronic pain to diseases of the brain.

20 Aug 2004

Emergency nursing shortage is worsening because of changing patient demographics and the aging of the emergency nurses population

As emergency departments across the country face increasing pressure from a nursing shortage and overcrowding, the nation’s emergency nurses will gather in San Diego Sept. 29 – Oct. 2, to seek opportunities to improve patient care, discuss ways to alleviate the difficult issues facing the profession, and learn about latest practices and innovations.

5 Aug 2004

A more direct lateral approach to minimally invasive procedures

Surgeons at the Cedars-Sinai Institute for Spinal Disorders describe in the August 1 issue of the journal Spine a minimally invasive approach that enables them to perform fusion surgery on the difficult-to-access upper lumbar region of the spine with a reduced risk of serious complications.

2 Aug 2004

Training in chronic care medicine is poor

In a national survey of practicing family physicians, pediatricians, internists and surgeons, the majority reported that their training in chronic care medicine was too thin overall to meet the demands of their practices.

27 May 2004

Prescription drugs imported by patients into the United States may be unsafe

Prescription drugs imported by patients into the United States may be unsafe, ineffective, adulterated, misbranded, expired or counterfeit, and could result in harm or death, according to AMA Trustee Rebecca J. Patchin, MD, who testified before the Department of Health and Human Services (HHS) Task Force on Drug Importation on May 14.

19 May 2004

$Trial of a drug derived from the puffer fish for treatment of refractory cancer pain$

Trial of a drug derived from the puffer fish for treatment of refractory cancer pain

Investigators involved in the pivotal clinical trial of TectinTM enrolled and dosed the first of up to 150 patients that will participate in the study. It is one of the largest Canadian clinical trials to evaluate the efficacy and safety of a drug for treatment of medically refractory cancer pain, and will take place in up to 25 treatment centres across Canada.

11 May 2004

New devices will help thousands of stroke victims recover mobility

Researchers from The University of Bath and the Chippenham Stroke Unit are playing a major role in a three-year programme to develop a special device which can be fitted inside caps or gloves.

6 May 2004

Anesthesiologists battle post-op pain

Post-operative pain is the No. 1 issue for people who've had surgery-and University of Utah anesthesiologists are helping these patients fight that battle on several fronts.

27 Apr 2004

First generic cultivate(R) cream to receive tentative FDA approval

Atrix Laboratories, Inc. announced today the company received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for fluticasone propionate cream, 0.05%.

27 Apr 2004

Two recent innovations look set to revolutionize biomedical treatment.

The first innovation is probably the world’s first multiple drug-eluting biodegradable stent for use in any part of the body where fluid flow, including blood, is disrupted.

19 Apr 2004

Video consultations to ease stress on frail patients

Monash University's Department of Geriatric Medicine is pioneering a high-tech way of consulting with elderly patients so they do not have to leave their nursing home beds.

4 Apr 2004

New Treatment for Chronic Head Pain

Dr. Levy pioneered a procedure known as supraorbital nerve stimulation or SOS, in which neurotransmitters are implanted into the forehead to block head pain. Tiny wires are burrowed under the skin until the precise location of pain is marked by a tingling response to electrical charge. The wires are kept in place for a week, and if pain is lessened and the patient is comfortable with the technology, neurotransmitters are surgically implanted under local anesthesia. The patient is able to control pain relief by manually adjusting the level of electrical stimulation through a hand held device.

22 Mar 2004

The placebo effect, study suggest pain management is possible

A Columbia professor has uncovered fresh evidence of the existence of the often-debated placebo effect. Even the professor himself, Tor D. Wager, of the Department of Psychology, was surprised by his team's findings. The study showed that the human brain processes pain differently when people believe that they have been given a pain-relieving skin cream. Wager, lead author of the study, defines "placebo" as a treatment that has no direct pharmacological effect and that may influence one's experience and physiology through one's beliefs.

22 Mar 2004

Atrix Signs Feasibility Agreement for Development of Two New Compounds

Atrix Laboratories, Inc. has announced today that the company has signed a limited feasibility agreement with Aventis SA (NYSE: AVE) to begin preliminary research on two proprietary Aventis compounds formulated in Atrix's delivery technology, Atrigel®. The current agreement is specific for these compounds in an undisclosed therapeutic area.

22 Mar 2004